Reaction of human α2‐antiplasmin and plasmin Stopped‐flow fluorescence kinetics

[1]  L. Sottrup-jensen,et al.  Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin. , 1995, The Biochemical journal.

[2]  L. Sottrup-jensen,et al.  Primary structure of bovine α2‐antiplasmin , 1994 .

[3]  J. Enghild,et al.  An examination of the inhibitory mechanism of serpins by analysing the interaction of trypsin and chymotrypsin with alpha 2-antiplasmin. , 1993, The Biochemical journal.

[4]  A. Johnsen,et al.  Different N-terminal forms of α2-plasmin inhibitor in human plasma , 1993 .

[5]  L. Sottrup-jensen,et al.  Bovine α2‐antiplasmin N‐Terminal and reactive site sequence , 1992 .

[6]  C. Ponting,et al.  Plasminogen: a structural review. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  K. Christiansen,et al.  Insertion of isolated insulin receptors into placental membrane vesicles. , 1992, The Biochemical journal.

[8]  O. Matsuo,et al.  On the molecular interactions between plasminogen-staphylokinase, α2-antiplasmin-formula> and fibrin , 1992 .

[9]  M. Llinás,et al.  A 1H-NMR study of plasminogen kringle 4 interactions with intact and partially digested fibrinogen , 1991 .

[10]  S. L. Gonias,et al.  Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin. , 1991, The Biochemical journal.

[11]  P. Gaffney,et al.  Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor. , 1991, Biochemistry.

[12]  R. Elliott,et al.  Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17. , 1990, Genomics.

[13]  E. Davie,et al.  Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. , 1990, The Journal of biological chemistry.

[14]  J. Potempa,et al.  The use of alpha 2-antiplasmin as a model for the demonstration of complex reversibility in serpins. , 1989, The Journal of biological chemistry.

[15]  S. Thorsen,et al.  The course and prerequisites of Lys-plasminogen formation during fibrinolysis. , 1988, Biochemistry.

[16]  Takashi Sasaki,et al.  Binding site of α2-plasmin inhibitor to plasminogen , 1988 .

[17]  J. Schaller,et al.  Structural aspects of the plasminogen of various species. , 1988, Enzyme.

[18]  M. Llinás,et al.  Isolation, purification and 1H-NMR characterization of a kringle 5 domain fragment from human plasminogen. , 1987, Biochimica et biophysica acta.

[19]  T. Marti,et al.  Amino acid sequence of the heavy chain of porcine plasmin. Comparison of the carbohydrate attachment sites with the human and bovine species , 1987 .

[20]  L. Nelles,et al.  Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin). , 1987, The Journal of biological chemistry.

[21]  J. Schaller,et al.  Complete amino acid sequence of bovine plasminogen. Comparison with human plasminogen. , 1985, European journal of biochemistry.

[22]  T. Marti,et al.  Determination of the complete amino-acid sequence of porcine miniplasminogen. , 1985, European journal of biochemistry.

[23]  U. Christensen.  C‐terminal lysine residues of fibrinogen fragments essential for binding to plasminogen , 1985, FEBS letters.

[24]  U. Christensen.  The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function. , 1984, The Biochemical journal.

[25]  M. Llinás,et al.  A 1H-NMR study of isolated domains from human plasminogen. Structural homology between kringles 1 and 4. , 1983, European journal of biochemistry.

[26]  G. Salvesen,et al.  Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.

[27]  T. Tamaki,et al.  Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. , 1982, The Journal of biological chemistry.

[28]  Z. Váli,et al.  Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4. , 1982, The Journal of biological chemistry.

[29]  S. Thorsen,et al.  Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin. , 1981, The Biochemical journal.

[30]  I. Clemmensen,et al.  Adsorption to fibrin of native fragments of known primary structure from human plasminogen. , 1981, Biochimica et biophysica acta.

[31]  F. Castellino,et al.  [29] Human plasminogen , 1981 .

[32]  C. Kluft,et al.  Demonstration of two forms of alpha 2-antiplasmin in plasma by modified crossed immunoelectrophoresis. , 1981, Thrombosis research.

[33]  B. Wiman.  Affinity-chromatographic purification of human α2-antiplasmin , 1980 .

[34]  U. Christensen,et al.  Requirements for Valid Assays of Clotting Enzymes Using Chromogenic Substrates , 1980, Thrombosis and Haemostasis.

[35]  P. Lerch,et al.  Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties. , 1980, European journal of biochemistry.

[36]  U. Christensen,et al.  Steady-state kinetics of plasmin- and trypsin-catalysed hydrolysis of a number of tripeptide-p-nitroanilides. , 1979, Biochimica et biophysica acta.

[37]  B. Wiman,et al.  On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen. , 1979, Biochimica et biophysica acta.

[38]  I. Clemmensen,et al.  Enzymic properties of the neo-plasmin-Val-422 (miniplasmin). , 1979, Biochimica et biophysica acta.

[39]  R. Priore,et al.  The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. , 1979, The Journal of biological chemistry.

[40]  I. Clemmensen,et al.  Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma. , 1978, The Biochemical journal.

[41]  U. Christensen.  Allosteric effects of some antifibrinolytic amino acids on the catalytic activity of human plasmin. , 1978, Biochimica et biophysica acta.

[42]  B. Wiman,et al.  On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin. , 1978, European journal of biochemistry.

[43]  B. Wiman,et al.  Molecular mechanism of physiological fibrinolysis , 1978, Nature.

[44]  I. Clemmensen,et al.  Kinetic properties of the primary inhibitor of plasmin from human plasma. , 1977, The Biochemical journal.

[45]  U. Christensen.  Kinetic studies of the urokinase-catalysed conversion of NH2-terminal glutamic acid plasminogen to plasmin. , 1977, Biochimica et biophysica acta.

[46]  N. Aoki,et al.  Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. , 1976, The Journal of biological chemistry.